Sort by
Refine Your Search
-
Listed
-
Employer
- Centre for Genomic Regulation
- Institute of Photonic Sciences
- Josep Carreras Leukaemia Research Institute (IJC)
- BIOGIPUZKOA HEALTH RESEARCH INSTITUTE
- CIC bioGUNE
- Centre de Recerca en Agrigenòmica
- Computer Vision Center
- ICMAB
- Institut Català de Nanociència i Nanotecnologia
- Institute for bioengineering of Catalonia, IBEC
- Institute of Chemical Research of Catalonia ICIQ
- UNIOVI
- Universitat Rovira i Virgili
- 3 more »
- « less
-
Field
-
of the reasons we have in place, at your disposal as a candidate, a mechanism to gather your suggestions/complaints concerning your candidate experience in our recruitment processes. Your feedback really matters
-
Website https://seuelectronica.urv.cat/treballar-a-la-urv/pi26032english.htm Requirements Research FieldChemistryEducation LevelPhD or equivalent Skills/Qualifications PhD in Chemistry, Photochemistry
-
postdoctoral researcher to join the research project STEPCAM (PID2024-157050NB-I00). The successful candidate will investigate the mechanisms controlling the dissolution, precipitation and polymorphic
-
cellular mechanisms underlying stress response, hematological malignancies and immune regulation. • Demonstrated experience working with mouse models (essential), preferably in the context of leukemia and/or
-
, the coupling between these, and the mechanisms of doping organic semiconductors. The successful candidate will work closely with experimental and theoretical partners across the consortium. They will be co
-
. For more information about the group, please visit http://www.crg.es/fatima_gebauer . Whom would we like to hire? Professional experience Must Have · You know how to perform 2D-PAGE · You have
-
mechanism of action that does not depend on chemistry at all. The Quasi-Living Materials Research Group is looking for a postdoctoral researcher to determine whether such a mechanism works inside biofilms
-
. Our goal is to identify the mechanisms that promote effective anti-tumor immune responses and to exploit these findings to develop novel therapeutic strategies. The team is part of the Oncology
-
available biomarkers often fail to detect responders and non-responders. As a result, most cancer patients are not receiving the right treatment and often only experience the side effects of toxic (and
-
applied research using plant experimental model systems, crops and farm animals) make extensive use of genomic technologies and large sets of genetic and genomic data (https://www.cragenomica.es/sites